Further, EGb could decrease the levels of alpha-fetoprotein (AFP), glypican-3 (GPC-3) and carcinoembryonic antigen (CEA) in HCC rats, suggesting that the anti-cancer efficacy of EGb was induced through its anti-proliferative and apoptotic properties in the HCC animal model. This evidence concerns the gene CEACAM5 and cancer.